C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2004
11/03/2004	EP0698101B1 Hepatitis-c virus type 4, 5 and 6
11/03/2004	EP0694042B1 Inhibitor of vascular endothelial cell growth factor
11/03/2004	EP0594843B1 Antibody assay for amylin
11/03/2004	CN1543571A Process for differential diagnosis of alzheimer's dementia in patients exhibiting mild cognitive impairment
11/03/2004	CN1543569A Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
11/03/2004	CN1543504A 疫苗 Vaccine
11/03/2004	CN1543476A Methods and compounds for the targeting of protein to exosomes
11/03/2004	CN1542131A Fermentation process for recombinant colibacillus
11/03/2004	CN1174099C Nucleic acid vaccines encoding G protein of respiratory syncytial virus
11/03/2004	CN1174097C Macrophage activating factors derived from cloned vitamin D binding protein
11/03/2004	CN1173991C Fik-1 as receiptor of growth factor of blood vessel inner-skin
11/03/2004	CN1173990C Depsipeptide compound
11/03/2004	CN1173738C Utilization of interferon alpha 5 in the preparation of drugs for viral hepatopathies
11/03/2004	CN1173733C Process for preparing dried soybean polypeptide powder with fat reducing action
11/02/2004	US6812379 Expression of eukaryotic peptides in plant plastids
11/02/2004	US6812335 Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same
11/02/2004	US6812328 High cooperativity in oxygen binding; rhb (beta n108q) exhibits enhanced stability against autoxidation; wherein the asparagine residue at position 108 of the beta-chains is replaced by a glutamine residue; genetic engeineering;
11/02/2004	US6812327 Neutrokine-alpha polypeptides
11/02/2004	US6812326 Tumor necrosis factor receptor-associated factor (traf) protein-interacting hereditary multiple extoses (trex) for use in the diagnosis and treatment of cancer and autoimmune disorders; antitummor agents
11/02/2004	US6812221 Immobilization
11/02/2004	US6812210 Urocortin-III and uses thereof
11/02/2004	US6812206 Contacting body fluid from mammal with antibody which binds to human aspartyl (asparaginyl) beta-hydroxylase (haah) polypeptide under conditions sufficient to form antigen-antibody complex and detecting complex
11/02/2004	US6812026 Antibodies directed against binding-associated epitopes
11/02/2004	US6812025 Detection of preferential enzyme inhibitors; obtain sample containing enzyme, incubate with modulator and nucleotide sequences, monitor amplification of preferential nucleotide sequences, absence of sequences indicates modulator
11/02/2004	US6811972 For preparing a hybridoma cell line which specifically recognizes and binds tumor associated antigen; antibodies; prostate carcinoma tumor antigen gene-1
11/02/2004	US6811970 Measurement of dimerization of viral polymerase; obtain sample containing viral dimerized proteins, incubate with binding agent, determine the amount of complex formed
11/02/2004	US6811787 Over-expressing homologous antigen vaccine and a method of making the same
11/02/2004	US6811780 Concurrent administering of cytokine antagonist and vaccine
11/02/2004	CA2283676C Stimulation, culture and preservation of pancreatic and other cells
11/02/2004	CA2111100C Interleukin-1 beta protease and interleukin-1 beta protease inhibitors
11/02/2004	CA2096911C Amyloid precursor protein protease
10/2004
10/28/2004	WO2004092393A1 Purification of polypeptides
10/28/2004	WO2004092391A2 Metabolic engineering for enhanced production of chitin and chitosan in microorganisms
10/28/2004	WO2004091552A2 Biodegradable glucosaminemuramyl peptides for apoptosis modulation
10/28/2004	WO2004091495A2 Compositions and methods related to production of erythropoietin
10/28/2004	WO2004076618A3 Genetically modified non-human mammals and cells
10/28/2004	WO2004070022A3 Use of oxalate deficient aspergillus niger strains for producing a polypeptide
10/28/2004	WO2004060145A3 Isolation and identification of cross-reactive t cells
10/28/2004	WO2004024748A3 High affinity monoclonal antibody for recognizing the progesterone receptor (pr) and method for creating the antibody
10/28/2004	WO2003105782A3 Specificity grafting of a murine antibody onto a human framework
10/28/2004	WO2003100020A3 Methods and constructs for high yield expression of clostripain
10/28/2004	WO2003052064A3 Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
10/28/2004	WO2003030833A3 Angiopoietin-2 specific binding agents
10/28/2004	WO2003020954A3 205p1b5 in treatment and detection of cancer
10/28/2004	WO2002088322A3 Cell adhesion and extracellular matrix proteins
10/28/2004	WO2001081540A3 Growth factor which acts through erb b-4 rtk
10/28/2004	US20040216180 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same
10/28/2004	US20040215008 Production of proteins by autoproteolytic cleavage
10/28/2004	US20040214995 Melanoma antigens and their use in diagnostic and therapeutic methods
10/28/2004	US20040214990 Transmembrane protein differentially expressed in cancer
10/28/2004	US20040214988 Preparing leucine zipper and coiled-coil proteins in which leucine residues have been replaced with 5,5,5-trifluoroleucines; site-directed mutagenesis; mimetics; improved heat/chemical resistance
10/28/2004	US20040214776 (truncated GDNF) proteins that promote dopamine uptake by dopaminergic cells and promote the survival of nerve cells
10/28/2004	US20040214760 Inhibition pf protein-phosphatases for the treatment of heart failure
10/28/2004	US20040214292 Method of producing template DNA and method of producing protein in cell-free protein synthesis system using the same
10/28/2004	US20040214286 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy
10/28/2004	US20040214283 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
10/28/2004	US20040214279 Insect monoamine transporter and methods of use thereof
10/28/2004	US20040214277 Methods and compositions for polypeptide engineering
10/28/2004	US20040214273 Method for secretory production of glycoprotein having human-type sugar chain using plant cell
10/28/2004	US20040214271 Process for producing recombined protein
10/28/2004	US20040214269 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/28/2004	US20040214268 Comprises nucleotide sequences coding membrane proteins for stimulating release of tumor necrosis factor and/or cell proliferation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/28/2004	US20040214267 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/28/2004	US20040214265 Comprises nucleotide sequences coding membrane proteins for stimulating release of tumor necrosis factor and/or cell proliferation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/28/2004	US20040214246 Monoclonal antibodies specific to pro-prostate specific antigen (PROPSA) for use as component of bioassy for detection of cancer
10/28/2004	US20040214239 Functional coupling of T1Rs and T2Rs by GI proteins, and cell-based assays for the identification of T1R and T2R modulators
10/28/2004	US20040214235 Immunoglobulin specific to tumor necrosis factor -related apoptosis-inducing ligand (TRAIL) for use in the prevention and treatment of cancer; immnotherapy
10/28/2004	US20040214230 Monoclonal antibody which binds galanin-lke peptides for use in diagnosis, prevention and treatment of obesity, sterility, collagen or rheumatic disease
10/28/2004	US20040214229 Amino acid sequences for use in diagnosis, prevention and treatment of sepsis and infections
10/28/2004	US20040214225 Immunoglobulin polypeptide for use as diagnostic tool in detecting variable major protein (VMP) of lymes disease; immunodiagnostics and genetic vaccines preventing parasitic infection
10/28/2004	US20040214190 Mammalian c-type lectins
10/28/2004	US20040214173 Anti-listeria bacteriocin
10/28/2004	US20040214172 Sheeplice, bovicola ovis, allergen treatment
10/28/2004	US20040214165 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
10/28/2004	US20040214160 Using viruses to detect or purify proteins
10/28/2004	US20040213804 Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an N-acryloylated polysaccharide
10/28/2004	US20040213802 Gene of novel corynebacterium diphtheriae antigen
10/28/2004	US20040213801 targets particular molecules that occur at the cell surface of HIV during viral entry into host cells; humoral response generated in vivo as a prophylactic measure in individuals to reduce or inhibit the ability of HIV to infect uninfected cells; mechanism of HIV cell entry
10/28/2004	US20040213797 Conjugates for the modulation of immune responses
10/28/2004	US20040213793 nucleic acid molecule encoding a transmembrane TEM1; Inhibiting neoangiogenesis by administering a molecule with an antibody variable region which specifically binds to an extracellular domain of a Tumor Endothelial Markers (TEMs) protein; polycystic kidney disease; psoriasis
10/28/2004	US20040213791 Monoclonal antibodies; for diagnosis and treatment of prostate cell proliferative disorders; immunogens; immunotherapy; cell lines
10/28/2004	US20040213790 VEGF-related protein
10/28/2004	US20040213762 A viral vector containing a nucleic acid sequence encoding V3 polypeptide or a biologically active fragment of the V3
10/28/2004	US20040213753 administrating to a skin or hair of a candidate a sponge protein hydrolysate which is a product by acidic hydrolysis of sponge skeleton fibers (spongin fibers) obtained from refined sponges as the raw material in an amount effective to stimulate cell growth of the skin or hair
10/28/2004	CA2521979A1 Compositions and methods related to production of erythropoietin
10/28/2004	CA2521718A1 Biodegradable glucosaminemuramyl peptides for apoptosis modulation
10/28/2004	CA2511946A1 Purification of polypeptides
10/27/2004	EP1471150A2 Plasmodium falciparum antigens inducing protective antibodies
10/27/2004	EP1471145A2 Pesticipal proteins and strains
10/27/2004	EP1471142A1 Heterodimeric receptor libraries using phagemids
10/27/2004	EP1471074A2 Methods for improving the conformation of proteins by means of reducing agents
10/27/2004	EP1470821A2 Cell therapy method for the treatment of tumours
10/27/2004	EP1470420A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
10/27/2004	EP1470238A2 Novel nucleic acids and polypeptides
10/27/2004	EP1470237A2 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria
10/27/2004	EP1470236A2 Methods and compositions for protein expression and purification
10/27/2004	EP1470229A1 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state
10/27/2004	EP1470223A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
10/27/2004	EP1470218A2 Corona-virus-like particles comprising functionally deleted genomes
10/27/2004	EP1470216A2 Hair follicle growth

1 ... 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 ... 1125